10mg

Semax

10mg

100.00$

Semax is studied for its involvement in cognitive function, neuroprotection, and stress-response signaling pathways. Research models often explore how this peptide influences memory formation, learning processes, and neural signaling efficiency.

Semax

Product Name: Semax

Type: Cognitive & Neuroprotective Research Peptide

Research Focus:

Semax is a synthetic heptapeptide analog of ACTH(4–10) developed in Russia and studied primarily for cognitive enhancement and neuroprotection[1][2]. While intranasal administration is most common in clinical literature, subcutaneous injection offers a convenient once‑daily alternative for research purposes[1][4]. This educational protocol presents a practical SC approach using straightforward reconstitution for accurate insulin‑syringe measurements.
Research Interest:

- Cognitive performance and memory pathway research
- Neuroplasticity and brain-derived neurotrophic factor (BDNF) studies
- Stress adaptation and resilience signaling models
- Focus, attention, and mental clarity pathways


Scientific Interest:

- Neurotrophic factor regulation
- Synaptic plasticity mechanisms
- Central nervous system signaling pathways


Reconstitution:

  • Reconstitute: Add 3.0 mLbacteriostatic water (max vial capacity) → ~3.33 mg/mLconcentration.

  • Typical daily range: 300–800 mcgonce daily (gradual titration recommended).

  • Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe.

  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles[2][9].

Cycle:

Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

WEEK

DAILY DOSE (MCG)

UNITS (PER INJECTION) (ML)

Weeks 1–2

300 mcg

9 units (0.09 mL)

Weeks 3–4

500 mcg

15 units (0.15 mL)

Weeks 5–6

600 mcg

18 units (0.18 mL)

Weeks 7–8

800 mcg

24 units (0.24 mL)

For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Frequency: Inject once dailysubcutaneously[1][4]. This schedule uses the largest practical dilution (3.0 mL) to ensure per‑injection volumes are accurate and manageable. Most human nootropic studies use intranasal dosing in the range of 400–900 mcg/day divided into multiple administrations[2][3]; this SC protocol delivers comparable total daily amounts in a single injection for convenience.

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with a sterile syringe.

  2. Inject slowly down the vial wall; avoid foaming.

  3. Gently swirl/roll until dissolved (do not shake vigorously).

  4. Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light[2].



IMPORTANT NOTICE:
This product is intended strictly for laboratory research. It is not intended to diagnose, treat, cure, or prevent any disease.

King St. West,
Toronto, Ontario
Canada.

M6K 3M3